Construction and analysis of variants of a polyvalent Lyme disease vaccine: approaches for improving the immune response to chimeric vaccinogens.
about
Vaccination against Lyme disease: past, present, and futureOspC phylogenetic analyses support the feasibility of a broadly protective polyvalent chimeric Lyme disease vaccineThe Position of His-Tag in Recombinant OspC and Application of Various Adjuvants Affects the Intensity and Quality of Specific Antibody Response after Immunization of Experimental MiceThe Treponema denticola FhbB Protein Is a Dominant Early Antigen That Elicits FhbB Variant-Specific Antibodies That Block Factor H Binding and Cleavage by Dentilisin.Live Attenuated Borrelia burgdorferi Targeted Mutants in an Infectious Strain Background Protect Mice from Challenge InfectionIdentification of Borrelia burgdorferi ospC genotypes in canine tissue following tick infestation: implications for Lyme disease vaccine and diagnostic assay designPrevention of lyme disease: promising research or sisyphean task?Lyme borreliosis: reviewing potential vaccines, clinical aspects and health economics.Assessment of the potential contribution of the highly conserved C-terminal motif (C10) of Borrelia burgdorferi outer surface protein C in transmission and infectivity.Rapid outer-surface protein C DNA tattoo vaccination protects against Borrelia afzelii infection.Disulfide-mediated oligomer formation in Borrelia burgdorferi outer surface protein C, a critical virulence factor and potential Lyme disease vaccine candidate.Epitope mapping of Borrelia burgdorferi OspC protein in homodimeric fold.Sequence Variation of Rare Outer Membrane Protein β-Barrel Domains in Clinical Strains Provides Insights into the Evolution of Treponema pallidum subsp. pallidum, the Syphilis Spirochete.
P2860
Q34327726-ECB52233-0171-4A14-B4F4-1651C936592CQ35783542-7B8169D5-8514-4B18-9E9F-4A8976E0FFF6Q35915376-075AC84E-270B-4BE2-B2EE-8C0259E11067Q37074007-81FF0A13-73D4-4C0E-B01B-86B9D53A89D7Q37163689-3D988262-FA15-47AF-9257-9904E4799F54Q37414209-DC3F91E5-8038-4C9C-A7EA-B49CFF620E7AQ37883972-AADE42B6-29A3-49D3-A2F5-E7F9F34EEC7BQ38594410-CBA12EB0-DD7E-431B-AEB8-67B9A9F39782Q41170680-5CB6460C-A2C5-4C0F-903F-B48E992F35B0Q41719890-05FD24F4-47DA-42F2-B4BD-4FF5A1B114C6Q42772775-6219DB12-EF99-4F18-94B1-FCA55806E366Q51159971-687A3037-9C5F-4DE3-A60D-038BA0A4CDB5Q55339367-747220BB-595B-4AB0-BD9F-24307B53857A
P2860
Construction and analysis of variants of a polyvalent Lyme disease vaccine: approaches for improving the immune response to chimeric vaccinogens.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 17 January 2007
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Construction and analysis of v ...... ponse to chimeric vaccinogens.
@en
Construction and analysis of v ...... ponse to chimeric vaccinogens.
@nl
type
label
Construction and analysis of v ...... ponse to chimeric vaccinogens.
@en
Construction and analysis of v ...... ponse to chimeric vaccinogens.
@nl
prefLabel
Construction and analysis of v ...... ponse to chimeric vaccinogens.
@en
Construction and analysis of v ...... ponse to chimeric vaccinogens.
@nl
P2860
P1433
P1476
Construction and analysis of v ...... sponse to chimeric vaccinogens
@en
P2093
Christopher G Earnhart
P2860
P304
P356
10.1016/J.VACCINE.2006.12.051
P407
P577
2007-01-17T00:00:00Z